| Product Name | MF | CAS | Details |
|---|
| H-QLPEATFMV-OH | Details |
| (2-indol-3-ylethyl)((2-(trifluoromethyl)phenyl)sulfonyl)amine | C17H15F3N2O2S | 880139-11-7 | Details |
| (1S,2R)-2-Methylcyclohexylamine hydrochloride | C7H16ClN | 79389-39-2 | Details |
| MCM4 antibody | Details |
| 1-(2,2-Diethoxyethyl)-1H-1,2,4-triazole-3-carbonitrile | C9H14N4O2 | 1338990-15-0 | Details |
| Amoxicillin EP impurity K | C16H19N3O5S | Details |
| PGA5 antibody | Details |
| {1-[(Dimethylamino)methyl]cyclohexyl}methanol hydrochloride | C10H22ClNO | 2248354-47-2 | Details |
| rac-(2R,4R,6S)-2,6-Dimethylpiperidine-4-carboxylic acid hydrochloride | C8H16ClNO2 | 2094020-19-4 | Details |
| 2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-4-(4-hydroxyphenyl)-2-methylbutanoic acid | C26H25NO5 | 1694765-91-7 | Details |
| Trimethylthiophene-3-sulfonyl fluoride | C7H9FO2S2 | 2138351-52-5 | Details |
| 3-(2-formylphenyl)benzoic acid | C14H10O3 | 205871-52-9 | Details |
| Recombinant Human SIGIRR | Details |
| 8-Bromoadenosine 5′-triphosphate sodium | C10H14BrN5NaO13P3 | 81035-56-5 | Details |
| 2-[(6-Aminopyridin-3-yl)(methyl)amino]ethan-1-ol | C8H13N3O | 884343-12-8 | Details |
| 1-Benzyl-1H-pyrrole-2-carboxylic acid | C12H11NO2 | 18159-22-3 | Details |
| 3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide | C18H22N2O3S2 | 300352-96-9 | Details |
| 2,4'-Difluorobenzophenone | C13H8F2O | 342-25-6 | Details |
| Benzenesulfonanilide | C12H11NO2S | 1678-25-7 | Details |
| Cyclododecane | C12H24 | 294-62-2 | Details |
| STK3 antibody | Details |
| 3-(3-Methylphenyl)-1-(1,2,3,4-tetrahydroquinolin-8-yl)urea | C17H19N3O | 1019116-11-0 | Details |
| 2-Hydroxy-N-1H-1,2,4-triazol-3-ylbenzamide | C9H8N4O2 | 36411-52-6 | Details |
| Isobutyl 2-cyanoacrylate | C8H11NO2 | 1069-55-2 | Details |
| 1-(5-Bromopyridin-2-yl)cyclobutane-1-carboxylic acid hydrochloride | 2138531-01-6 | Details |
| Recombinant Mouse IGFBP-6 | Details |
| (2S)-2-(3,4-Difluorophenyl)oxirane | C8H6F2O | 1006376-63-1 | Details |
| 5-Bromo-6-methoxynicotinaldehyde | C7H6BrNO2 | 65873-73-6 | Details |
| Prulifloxacin | C21H20FN3O6S | 123447-62-1 | Details |
| H-GELDRWEKIRLRPGG-OH | Details |
| 2,3-Dihydro-pyrazolo[5,1-b]thiazole-7-carboxylic acid | C6H6N2O2S | 933753-92-5 | Details |
| 4-Methylphthalazin-1-amine | C9H9N3 | 4776-85-6 | Details |
| Ethyl 1-cyclopropanecarbonylpiperidine-3-carboxylate | C12H19NO3 | 1153068-27-9 | Details |
| Burnettramic acid A aglycone | C35H61NO7 | 2396676-46-1 | Details |
| SLC5A9 Blocking Peptide | Details |
| ART5 Blocking Peptide | Details |
| Selenium dioxide | O2Se | 7446-08-4 | Details |
| Andarine | C19H18F3N3O6 | 401900-40-1 | Details |
| Eriosematin | C19H20O4 | 168010-17-1 | Details |
| Ethyl 2,3-dihydro-1H-indole-3-carboxylate hydrochloride | C11H14ClNO2 | 1158918-79-6 | Details |
| (Z)-N'-Hydroxy-1,6-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboximidamide | C7H10N4O3 | 2060523-60-4 | Details |
| 2-(5-Chloro-2-methylphenoxy)acetic acid | C9H9ClO3 | 25141-38-2 | Details |
| COPZ1 antibody | Details |
| 2-{[(2,2,2-Trifluoroethoxy)carbonyl]amino}acetic acid | C5H6F3NO4 | 37888-15-6 | Details |
| 4-Bromo-5,6,7,8-tetrahydroisoquinolin-8-ol | C9H10BrNO | 1428652-84-9 | Details |
| 2,2,2-Trifluoro-1-(piperidin-2-yl)ethan-1-ol hydrochloride | 1283720-38-6 | Details |
| Bis[rhodium(±,±,±',±'-tetramethyl-1,3-benzenedipropionic Acid)] | 2C16H22O4.Rh2 | 819050-89-0 | Details |
| PPP6C antibody | Details |
| Methyl 4-[(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl]benzoate | C14H15N3O4 | 879773-55-4 | Details |
| Methyl 3-aminohexanoate hydrochloride | C7H16ClNO2 | 1217530-84-1 | Details |
| Glutathione Peroxidase 2 antibody | Details |
| 1,1-Cyclopropanedicarboxylic acid | C5H6O4 | 598-10-7 | Details |
| LRRC8B antibody | Details |
| 1-(Piperidin-3-ylmethyl)-4-(pyridin-2-yl)piperazine | C15H24N4 | 896054-31-2 | Details |
| RNPEPL1 Blocking Peptide | Details |
| 1,2,3-Tri-O-benzyl-4,6-O-benzylidene-b-D-glucopyranoside | C34H34O6 | 57783-66-1 | Details |
| 3-{[4-(Trifluoromethyl)phenyl]methyl}oxolan-3-amine hydrochloride | C12H15ClF3NO | 1803604-11-6 | Details |
| {5-Oxaspiro[3.5]nonan-6-yl}methanesulfonyl chloride | C9H15ClO3S | 2126177-51-1 | Details |
| 5-tert-Butyl-4-ethyl-1,3-thiazol-2-amine | C9H16N2S | 34631-47-5 | Details |
| Periostin antibody | Details |
| N,N-Dimethylmorpholine-4-sulfonamide | C6H14N2O3S | 5433-57-8 | Details |
| 1-(1-Benzylpyrrolidin-3-yl)ethan-1-one | C13H17NO | 87088-73-1 | Details |
| 3,4-Dihydro-2H-1-benzothiopyran-4-carboxylic acid | C10H10O2S | 80858-99-7 | Details |
| Octaneuropeptide | C41H74N12O11 | Details |
| 2-Amino-3-(4-fluorophenyl)-2-methylpropanoic acid hydrochloride | C10H13ClFNO2 | 2060042-34-2 | Details |
| 2-Methyl-4-[(propan-2-yl)amino]benzamide | C11H16N2O | 1258651-32-9 | Details |
| 2-Chloroethanesulfonic acid sodium hydrate | Details |
| 2-(3-(4-Fluorobenzyl)-2-oxoimidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide | C21H20FN5O2S | 1072803-08-7 | Details |
| [1-(2-Methylpropyl)-1H-pyrazol-3-yl]methanamine | C8H15N3 | 1334492-60-2 | Details |
| C16ORF48 Blocking Peptide | Details |
| Cergutuzumab | 1509916-03-3 | Details |
| 1-(5-Ethyl-1,2,4-oxadiazol-3-yl)cyclopentan-1-amine hydrochloride | C9H16ClN3O | 1375472-78-8 | Details |
| HADH Blocking Peptide | Details |
| 4-(4-Cyclopropyl-4H-1,2,4-triazol-3-yl)piperidine dihydrochloride | 1269151-60-1 | Details |
| H-GCVLS-OH | Details |
| 4-Aminocycloheptane-1-carboxylic acid hydrochloride | C8H16ClNO2 | 2260931-71-1 | Details |
| (2-(4-fluoro-3-methylphenyl)-6,6-dimethyl(5,6,7-trihydroindol))-4-O-methyloxime | C18H21FN2O | 1274948-04-7 | Details |
| 7(Z)-Nonadecenoic acid | C19H36O2 | 118020-79-4 | Details |
| PPP2R3B Blocking Peptide | Details |
| Methyl 2-[(methylamino)oxy]acetate hydrochloride | 2138098-53-8 | Details |
| 1-(1-Methyl-1H-pyrazol-4-yl)-2-(piperazin-1-yl)ethan-1-ol | C10H18N4O | 1354952-22-9 | Details |
| 2-(4-Amino-3-fluorophenoxy)-N,N-dimethylacetamide | C10H13FN2O2 | 1249677-08-4 | Details |
| CORO2B antibody | Details |
| Sodium monododecyl phosphate(contains<10% sodium didodecyl phosphate) | C12H28NaO4P | 17026-83-4 | Details |
| Elgemtumab | 1512559-37-3 | Details |
| 5,6-Diamino-1,3-dimethyl-2,3-dihydro-1H-1,3-benzodiazol-2-one | C9H12N4O | 98953-81-2 | Details |
| Methyl 2,3,4-trifluorobenzoate | C8H5F3O2 | 773873-68-0 | Details |
| Alphadolone | C21H32O4 | 14107-37-0 | Details |
| 4-(Dimethylsulfamoyl)-1-methyl-1H-pyrrole-2-carboxylic acid | C8H12N2O4S | 937613-15-5 | Details |
| 4-(Aminomethyl)-N-ethyl-N-methylpyridin-2-amine dihydrochloride | C9H15N3.2[HCl] | 1311314-53-0 | Details |
| [Dibromo(fluoro)methyl]benzene | C7H5Br2F | 772339-79-4 | Details |
| H-K^AEEGDLLVNPDQPR^-OH | Details |
| H-NYLNYGEEGAPGK^-OH | Details |
| Tetrahydroabietyl alcohol | C20H36O | 13393-93-6 | Details |
| TPMPA | C6H12NO2P | 182485-36-5 | Details |
| Methyl 3-bromo-4-(carbamothioylamino)benzoate | C9H9BrN2O2S | 2138055-83-9 | Details |
| 2-[4-(Aminomethyl)piperidin-1-yl]pyridine-3-carboxamide dihydrochloride | C12H20Cl2N4O | 1333641-79-4 | Details |
| Goat anti Monkey IgM (Alk Phos) | Details |
| 1-O-(trans-3-Hydroxycotinine)-2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester | Details |
| IKappaB beta antibody (Thr19) | Details |
| Product Total： Product Page： | ||||
| 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 | ||||